A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NDMC / N-desmethylclozapine

[Related PubMed/MEDLINE]
Total Number of Papers: 35
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NDMC  (>> Co-occurring Abbreviation)
Long Form:   N-desmethylclozapine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Discovery of Procognitive Antipsychotics by Combining Muscarinic M1 Receptor Structure-Activity Relationship with Systems Response Profiles in Zebrafish Larvae. SAR
2020 The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy. CLZ
2019 Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism. CLZ, VPA
2019 The role of dopamine D1- and D2-like receptors related to muscarinic M1 receptors in impulsive choice in high-impulsive and low-impulsive rats. HI, LI
2017 Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients. ---
2016 An ex Vivo Model for Evaluating Blood-Brain Barrier Permeability, Efflux, and Drug Metabolism. CNO
2016 Electrophysiological evidence showing muscarinic agonist-antagonist activities of N-desmethylclozapine using hippocampal excitatory and inhibitory neurons. Oxo-M
2016 The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review. ---
2015 Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex. ACh, EPSP
10  2015 Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. MCCB
11  2013 Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia. AA, COX-2, PGE2, PUFAs, TXA2, TXB2
12  2012 Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. ---
13  2012 Impact of clozapine, N-desmethylclozapine and chlorpromazine on thromboxane production in vitro. AP, APs, CPZ, TSST-1, TXA2, TXB2
14  2012 Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. ---
15  2011 Ameliorative effect of N-desmethylclozapine in animal models of social deficits and cognitive functions. a,d, NMDA
16  2011 Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors. PPI
17  2011 Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-Possible involvement of muscarinic receptors. PPI
18  2011 Effects of clozapine and N-desmethylclozapine on synaptic transmission at hippocampal inhibitory and excitatory synapses. ---
19  2011 In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. DDM-RGH-188
20  2011 Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of delta-opioid receptor. CHO/DOR, GSK-3beta, IGF-I, PI3K
21  2011 The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. BDNF, NOR
22  2010 N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M(1) receptor. ---
23  2009 Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex. ---
24  2009 Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex. DA, mPFC
25  2009 Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors. ACh, mAChR
26  2009 N-desmethylclozapine: is there evidence for its antipsychotic potential? ---
27  2009 The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. CLZ
28  2008 Role of muscarinic receptors in the activity of N-desmethylclozapine: reversal of hyperactivity in the phospholipase C knockout mouse. ---
29  2007 Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome. ---
30  2007 Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies. AIL, CAR
31  2007 N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors. CHO, CHO/DOR
32  2007 Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. ---
33  2007 Pharmacology of N-desmethylclozapine. ---
34  2005 N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. ACh, DA, mPFC, NAc
35  2004 The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. MAP kinase